Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines
Authors:
- Rebecca PateniaRPRebecca Patenia
- Stacie GallardoSGStacie Gallardo
- Karolina MelicharováKMKarolina Melicharová
- Wei HuWHWei Hu
- Ralph S. FreedmanRFRalph S. Freedman
- 1 March 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (3) , 707-713
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretionMolecular Pathology, 2002
- Phase I Study of Recombinant Human CD40 Ligand in Cancer PatientsJournal of Clinical Oncology, 2001
- CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor SuperfamilyMolecular and Cellular Biology, 2000
- CD40-CD40 ligandJournal of Leukocyte Biology, 2000
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable AnginaCirculation, 1999
- Inhibition of Human Breast Carcinoma Growth by a Soluble Recombinant Human CD40 LigandBlood, 1999
- Incorporation of an Isoleucine Zipper Motif Enhances the Biological Activity of Soluble CD40L (CD154)Journal of Biological Chemistry, 1999
- Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesClinical and Experimental Immunology, 1998
- Characterization of an ovarian carcinoma cell lineCancer, 1978